# Implantation or Injectable Dosage Form New Animal Drugs; Insulin
> **Food and Drug Administration** · Final rule. · Published 2008-04-18 · Effective 2008-04-18 · 73 FR 21042
## Document
- **Document number:** E8-8347
- **Category:** other
- **Sub-agency:** Food and Drug Administration
- **Federal Register citation:** 73 FR 21042
- **CFR reference:** 21 CFR 522
- **Publication date:** 2008-04-18
- **Effective date:** 2008-04-18
## Abstract

The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval of a supplemental new animal drug application (NADA) filed by Intervet, Inc. The supplemental NADA provides for the veterinary prescription use of an injectable suspension of porcine insulin zinc for the reduction of hyperglycemia and hyperglycemia-associated clinical signs in cats with diabetes mellitus.

## Source
- [Federal Register document](https://www.federalregister.gov/documents/2008/04/18/E8-8347/implantation-or-injectable-dosage-form-new-animal-drugs-insulin)
---
*AI Analytics · CC0 1.0*